A double-Blind, Randomised, Placebo-Controlled, Parallel Group Phase 1/11, First-in-Human Study to Assess the Safety and Efficacy of Two Doses of SX600 Administered by Lumbosacral Transforaminal Epidural Injection in Patients with Radicular Pain Secondary to Lumbar Intervertebral Disc Hernaiation
